| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Surgical Procedures | 30 | 2020 | 1506 | 2.180 |
Why?
|
| Photochemotherapy | 22 | 2004 | 828 | 2.050 |
Why?
|
| Carotid Stenosis | 23 | 2020 | 858 | 1.920 |
Why?
|
| Endarterectomy, Carotid | 19 | 2023 | 556 | 1.690 |
Why?
|
| Blood Vessel Prosthesis Implantation | 22 | 2022 | 1456 | 1.490 |
Why?
|
| Tunica Intima | 14 | 2011 | 455 | 1.480 |
Why?
|
| Ischemia | 17 | 2018 | 1905 | 1.430 |
Why?
|
| Carotid Body Tumor | 4 | 2020 | 34 | 1.200 |
Why?
|
| Blood Vessel Prosthesis | 21 | 2022 | 956 | 1.120 |
Why?
|
| Aortic Aneurysm, Abdominal | 24 | 2022 | 1250 | 1.120 |
Why?
|
| Angioplasty, Balloon | 14 | 2011 | 592 | 1.070 |
Why?
|
| Arterial Occlusive Diseases | 13 | 2010 | 742 | 0.990 |
Why?
|
| Carotid Artery, Internal | 6 | 2018 | 440 | 0.960 |
Why?
|
| Lower Extremity | 6 | 2012 | 1217 | 0.930 |
Why?
|
| Endovascular Procedures | 11 | 2022 | 2215 | 0.900 |
Why?
|
| Intermittent Claudication | 7 | 2012 | 305 | 0.880 |
Why?
|
| Muscle, Smooth, Vascular | 10 | 2004 | 1494 | 0.760 |
Why?
|
| Stents | 20 | 2021 | 3193 | 0.750 |
Why?
|
| Femoral Artery | 14 | 2009 | 827 | 0.730 |
Why?
|
| Leg | 11 | 2012 | 1087 | 0.690 |
Why?
|
| Carotid Arteries | 11 | 2020 | 932 | 0.650 |
Why?
|
| Aorta, Abdominal | 18 | 2003 | 627 | 0.620 |
Why?
|
| Popliteal Artery | 4 | 2009 | 313 | 0.570 |
Why?
|
| Peripheral Vascular Diseases | 5 | 2010 | 488 | 0.570 |
Why?
|
| Iliac Artery | 9 | 2011 | 344 | 0.570 |
Why?
|
| Hyperplasia | 19 | 2011 | 1150 | 0.540 |
Why?
|
| Postoperative Complications | 36 | 2021 | 15831 | 0.520 |
Why?
|
| Prosthesis Failure | 3 | 2012 | 1208 | 0.520 |
Why?
|
| Photosensitizing Agents | 9 | 2002 | 627 | 0.510 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2015 | 317 | 0.500 |
Why?
|
| Specialties, Surgical | 1 | 2019 | 391 | 0.480 |
Why?
|
| Peripheral Arterial Disease | 5 | 2020 | 1304 | 0.470 |
Why?
|
| Extracellular Matrix | 6 | 2004 | 1730 | 0.460 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2015 | 234 | 0.460 |
Why?
|
| Catheterization | 5 | 2011 | 1429 | 0.420 |
Why?
|
| Graft Occlusion, Vascular | 5 | 2009 | 538 | 0.410 |
Why?
|
| Aorta, Thoracic | 4 | 2014 | 1110 | 0.400 |
Why?
|
| Organometallic Compounds | 9 | 2000 | 647 | 0.390 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2015 | 1352 | 0.380 |
Why?
|
| Wounds, Penetrating | 1 | 2014 | 316 | 0.370 |
Why?
|
| Thrombosis | 5 | 2011 | 2953 | 0.370 |
Why?
|
| Aneurysm | 3 | 2010 | 343 | 0.370 |
Why?
|
| Time Factors | 47 | 2021 | 40149 | 0.360 |
Why?
|
| Urinary Retention | 2 | 2023 | 100 | 0.360 |
Why?
|
| Transplantation Tolerance | 4 | 2018 | 641 | 0.350 |
Why?
|
| Carotid Artery Diseases | 7 | 2020 | 872 | 0.350 |
Why?
|
| Vascular Patency | 13 | 2012 | 915 | 0.350 |
Why?
|
| Treatment Outcome | 57 | 2023 | 65286 | 0.340 |
Why?
|
| Aortic Aneurysm, Thoracic | 8 | 2019 | 708 | 0.330 |
Why?
|
| Risk Assessment | 23 | 2021 | 24299 | 0.330 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2010 | 153 | 0.330 |
Why?
|
| Laser Therapy | 10 | 2002 | 1108 | 0.330 |
Why?
|
| Thrombectomy | 2 | 2010 | 676 | 0.330 |
Why?
|
| Vena Cava Filters | 1 | 2012 | 270 | 0.330 |
Why?
|
| Patient Care Team | 1 | 2020 | 2519 | 0.320 |
Why?
|
| Saphenous Vein | 4 | 2009 | 519 | 0.320 |
Why?
|
| Major Histocompatibility Complex | 4 | 2015 | 880 | 0.310 |
Why?
|
| Limb Salvage | 8 | 2013 | 488 | 0.310 |
Why?
|
| Angioplasty | 5 | 2016 | 355 | 0.310 |
Why?
|
| Aneurysm, Infected | 1 | 2009 | 82 | 0.310 |
Why?
|
| Graft Rejection | 8 | 2018 | 4504 | 0.310 |
Why?
|
| Kaplan-Meier Estimate | 19 | 2017 | 6514 | 0.310 |
Why?
|
| Blood Coagulation Disorders | 2 | 2010 | 350 | 0.310 |
Why?
|
| Crowns | 1 | 2009 | 156 | 0.310 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2015 | 1802 | 0.310 |
Why?
|
| Renal Artery Obstruction | 7 | 2012 | 216 | 0.300 |
Why?
|
| Prosthesis Implantation | 1 | 2012 | 594 | 0.300 |
Why?
|
| Heart Transplantation | 7 | 2018 | 3306 | 0.290 |
Why?
|
| Streptococcus agalactiae | 1 | 2009 | 337 | 0.290 |
Why?
|
| Indoles | 9 | 2000 | 1834 | 0.280 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 1999 | 590 | 0.280 |
Why?
|
| Renal Artery | 9 | 2012 | 355 | 0.280 |
Why?
|
| Brachial Artery | 2 | 2002 | 373 | 0.270 |
Why?
|
| Anticoagulants | 3 | 2011 | 4854 | 0.270 |
Why?
|
| Blood Vessels | 3 | 2002 | 1111 | 0.270 |
Why?
|
| Aged | 94 | 2022 | 171344 | 0.270 |
Why?
|
| Swine, Miniature | 7 | 2018 | 972 | 0.270 |
Why?
|
| Arteriosclerosis | 10 | 2004 | 1055 | 0.270 |
Why?
|
| Flow Cytometry | 2 | 2015 | 5890 | 0.250 |
Why?
|
| Histocompatibility | 3 | 2015 | 327 | 0.250 |
Why?
|
| Retrospective Studies | 54 | 2023 | 81657 | 0.250 |
Why?
|
| Specialization | 2 | 2020 | 779 | 0.250 |
Why?
|
| Endarterectomy | 8 | 2009 | 196 | 0.240 |
Why?
|
| Risk Factors | 41 | 2022 | 74889 | 0.240 |
Why?
|
| Cattle | 9 | 2004 | 3815 | 0.240 |
Why?
|
| Aortic Aneurysm | 7 | 2021 | 649 | 0.240 |
Why?
|
| Jugular Veins | 2 | 2004 | 211 | 0.230 |
Why?
|
| Health Status Indicators | 1 | 2010 | 968 | 0.230 |
Why?
|
| Hemoglobinometry | 1 | 2004 | 35 | 0.230 |
Why?
|
| Heparin | 1 | 2011 | 1636 | 0.230 |
Why?
|
| Endoleak | 2 | 2021 | 111 | 0.230 |
Why?
|
| Cells, Cultured | 14 | 2015 | 18986 | 0.220 |
Why?
|
| Thrombocytopenia | 1 | 2011 | 1172 | 0.220 |
Why?
|
| Deferoxamine | 1 | 2004 | 155 | 0.220 |
Why?
|
| Swine | 9 | 2018 | 5985 | 0.220 |
Why?
|
| Free Radical Scavengers | 1 | 2004 | 213 | 0.210 |
Why?
|
| Thrombomodulin | 1 | 2003 | 107 | 0.210 |
Why?
|
| Oxyhemoglobins | 1 | 2004 | 213 | 0.210 |
Why?
|
| Male | 107 | 2023 | 364154 | 0.210 |
Why?
|
| Lasers | 4 | 2001 | 951 | 0.210 |
Why?
|
| Lung Transplantation | 3 | 2018 | 1310 | 0.200 |
Why?
|
| Stem Cells | 1 | 2015 | 3536 | 0.200 |
Why?
|
| Odds Ratio | 13 | 2017 | 9661 | 0.200 |
Why?
|
| Gamma Rays | 2 | 2004 | 324 | 0.200 |
Why?
|
| Carotid Artery Injuries | 2 | 2000 | 96 | 0.200 |
Why?
|
| Stroke | 12 | 2020 | 9744 | 0.200 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2004 | 833 | 0.200 |
Why?
|
| Survival Rate | 18 | 2016 | 12826 | 0.200 |
Why?
|
| Aged, 80 and over | 44 | 2021 | 59548 | 0.200 |
Why?
|
| Humans | 137 | 2023 | 766812 | 0.200 |
Why?
|
| Aortic Diseases | 7 | 2014 | 741 | 0.200 |
Why?
|
| Spectrum Analysis | 1 | 2004 | 443 | 0.190 |
Why?
|
| Radiation-Sensitizing Agents | 5 | 1997 | 348 | 0.190 |
Why?
|
| Female | 98 | 2022 | 396532 | 0.190 |
Why?
|
| Thromboplastin | 1 | 2003 | 289 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2004 | 8108 | 0.190 |
Why?
|
| Hypertension, Renovascular | 3 | 2012 | 115 | 0.190 |
Why?
|
| Organ Preservation | 2 | 2015 | 400 | 0.190 |
Why?
|
| Reoperation | 10 | 2013 | 4325 | 0.180 |
Why?
|
| Cell Adhesion | 3 | 2004 | 3093 | 0.180 |
Why?
|
| Patient Selection | 11 | 2013 | 4252 | 0.180 |
Why?
|
| Carotid Artery, Common | 3 | 2016 | 172 | 0.180 |
Why?
|
| Embolic Protection Devices | 1 | 2020 | 43 | 0.170 |
Why?
|
| Perfusion | 3 | 2015 | 1409 | 0.170 |
Why?
|
| Proportional Hazards Models | 15 | 2021 | 12536 | 0.170 |
Why?
|
| Rats | 20 | 2004 | 23717 | 0.170 |
Why?
|
| Middle Aged | 66 | 2021 | 223267 | 0.170 |
Why?
|
| Sterilization | 1 | 2001 | 132 | 0.170 |
Why?
|
| Methylene Blue | 1 | 2000 | 156 | 0.170 |
Why?
|
| Blood Substitutes | 1 | 2000 | 57 | 0.170 |
Why?
|
| Endothelium, Vascular | 3 | 2003 | 4424 | 0.160 |
Why?
|
| Monitoring, Intraoperative | 5 | 2012 | 947 | 0.160 |
Why?
|
| Graft Survival | 6 | 2018 | 3904 | 0.160 |
Why?
|
| Venous Thromboembolism | 1 | 2012 | 1883 | 0.160 |
Why?
|
| Art | 1 | 2019 | 65 | 0.160 |
Why?
|
| Porphyrins | 2 | 1999 | 352 | 0.160 |
Why?
|
| Indium Radioisotopes | 2 | 1989 | 114 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 2 | 1997 | 1996 | 0.160 |
Why?
|
| Arm | 1 | 2002 | 591 | 0.160 |
Why?
|
| Brain Ischemia | 3 | 2018 | 3001 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Duplex | 5 | 2016 | 198 | 0.160 |
Why?
|
| Angiography | 10 | 2017 | 1595 | 0.160 |
Why?
|
| Animals | 46 | 2018 | 168939 | 0.150 |
Why?
|
| Intracellular Membranes | 1 | 1999 | 386 | 0.150 |
Why?
|
| Carotenoids | 3 | 1991 | 620 | 0.150 |
Why?
|
| Hypotension | 2 | 2023 | 887 | 0.150 |
Why?
|
| Coronary Restenosis | 1 | 2001 | 396 | 0.150 |
Why?
|
| Mesenteric Vascular Occlusion | 2 | 2009 | 93 | 0.150 |
Why?
|
| Prosthesis Design | 6 | 2022 | 2120 | 0.150 |
Why?
|
| Hemoglobins | 2 | 2004 | 1531 | 0.150 |
Why?
|
| Predictive Value of Tests | 8 | 2015 | 15425 | 0.150 |
Why?
|
| Cerebral Revascularization | 1 | 2020 | 260 | 0.140 |
Why?
|
| Kidney Transplantation | 4 | 2018 | 4278 | 0.140 |
Why?
|
| Vocal Cord Paralysis | 1 | 2020 | 275 | 0.140 |
Why?
|
| Staphylococcal Infections | 2 | 2001 | 1396 | 0.140 |
Why?
|
| Immune Tolerance | 2 | 2015 | 2328 | 0.130 |
Why?
|
| Registries | 5 | 2020 | 8352 | 0.130 |
Why?
|
| Logistic Models | 12 | 2021 | 13276 | 0.130 |
Why?
|
| Radiography | 9 | 2014 | 6968 | 0.130 |
Why?
|
| Lipids | 2 | 2005 | 3322 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2016 | 2306 | 0.130 |
Why?
|
| Tunica Media | 2 | 2011 | 107 | 0.130 |
Why?
|
| Cell Division | 7 | 1999 | 4473 | 0.130 |
Why?
|
| Fascia | 1 | 1996 | 143 | 0.130 |
Why?
|
| Aortic Rupture | 10 | 2021 | 322 | 0.120 |
Why?
|
| Databases as Topic | 4 | 2011 | 472 | 0.120 |
Why?
|
| Aluminum | 5 | 1997 | 150 | 0.120 |
Why?
|
| Muscle Weakness | 1 | 2018 | 412 | 0.120 |
Why?
|
| Prosthesis-Related Infections | 1 | 2001 | 497 | 0.120 |
Why?
|
| Arteries | 5 | 1994 | 1123 | 0.120 |
Why?
|
| Reperfusion Injury | 3 | 2008 | 1043 | 0.120 |
Why?
|
| Hindlimb | 3 | 2013 | 513 | 0.120 |
Why?
|
| Chi-Square Distribution | 7 | 2017 | 3431 | 0.120 |
Why?
|
| Embolism | 2 | 2018 | 401 | 0.120 |
Why?
|
| Boston | 9 | 2016 | 9346 | 0.120 |
Why?
|
| Muscle, Skeletal | 4 | 2018 | 4968 | 0.120 |
Why?
|
| Brain Death | 1 | 2018 | 360 | 0.120 |
Why?
|
| Severity of Illness Index | 12 | 2018 | 15912 | 0.120 |
Why?
|
| Neurosurgery | 1 | 2020 | 682 | 0.110 |
Why?
|
| Histocompatibility Antigens | 1 | 2015 | 479 | 0.110 |
Why?
|
| Vasa Vasorum | 1 | 2013 | 25 | 0.110 |
Why?
|
| Fibromuscular Dysplasia | 1 | 1994 | 55 | 0.110 |
Why?
|
| Muscle Strength | 1 | 2018 | 639 | 0.110 |
Why?
|
| Clinical Competence | 2 | 2019 | 4858 | 0.110 |
Why?
|
| Pericardiocentesis | 1 | 2014 | 78 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2018 | 3250 | 0.110 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 18329 | 0.110 |
Why?
|
| Angioscopy | 1 | 1993 | 47 | 0.110 |
Why?
|
| Propensity Score | 3 | 2019 | 1972 | 0.110 |
Why?
|
| Blood Platelets | 2 | 2002 | 2465 | 0.110 |
Why?
|
| Diverticulum | 1 | 2014 | 137 | 0.110 |
Why?
|
| Follow-Up Studies | 20 | 2017 | 39312 | 0.110 |
Why?
|
| Diabetes Complications | 2 | 2010 | 1319 | 0.110 |
Why?
|
| Blood Transfusion | 1 | 2000 | 1308 | 0.100 |
Why?
|
| Intraoperative Complications | 4 | 2010 | 1171 | 0.100 |
Why?
|
| Skin Transplantation | 2 | 2015 | 1097 | 0.100 |
Why?
|
| Veins | 3 | 1996 | 769 | 0.100 |
Why?
|
| Age Factors | 4 | 2020 | 18397 | 0.100 |
Why?
|
| Inguinal Canal | 1 | 2012 | 71 | 0.100 |
Why?
|
| Free Radicals | 3 | 1997 | 237 | 0.100 |
Why?
|
| Recurrence | 8 | 2014 | 8507 | 0.100 |
Why?
|
| Asymptomatic Diseases | 4 | 2018 | 588 | 0.100 |
Why?
|
| Magnetic Resonance Angiography | 5 | 2018 | 1428 | 0.100 |
Why?
|
| Spinal Cord Ischemia | 2 | 2011 | 94 | 0.100 |
Why?
|
| Kidney | 4 | 2015 | 7073 | 0.100 |
Why?
|
| Multivariate Analysis | 8 | 2017 | 12064 | 0.100 |
Why?
|
| Reference Standards | 1 | 2015 | 1010 | 0.100 |
Why?
|
| Diabetic Foot | 1 | 2016 | 382 | 0.100 |
Why?
|
| Heart | 2 | 2015 | 4425 | 0.090 |
Why?
|
| Platelet Factor 4 | 1 | 2011 | 131 | 0.090 |
Why?
|
| Cranial Nerve Injuries | 1 | 2010 | 27 | 0.090 |
Why?
|
| Aortography | 3 | 2010 | 423 | 0.090 |
Why?
|
| Neointima | 1 | 2011 | 133 | 0.090 |
Why?
|
| Fingers | 1 | 1994 | 508 | 0.090 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2011 | 284 | 0.090 |
Why?
|
| Motor Cortex | 1 | 2018 | 1005 | 0.090 |
Why?
|
| Ureteral Obstruction | 1 | 2012 | 293 | 0.090 |
Why?
|
| Gallium Radioisotopes | 1 | 1991 | 195 | 0.090 |
Why?
|
| Dissection | 1 | 1992 | 298 | 0.090 |
Why?
|
| Tissue Donors | 3 | 2018 | 2392 | 0.090 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 551 | 0.090 |
Why?
|
| Embolization, Therapeutic | 4 | 2008 | 1403 | 0.090 |
Why?
|
| Hypoglossal Nerve Diseases | 1 | 2010 | 8 | 0.090 |
Why?
|
| Leadership | 1 | 2019 | 1394 | 0.090 |
Why?
|
| Iliac Aneurysm | 2 | 2000 | 37 | 0.090 |
Why?
|
| Cryopreservation | 1 | 2015 | 727 | 0.090 |
Why?
|
| Skin | 1 | 2004 | 4499 | 0.090 |
Why?
|
| Chronic Disease | 5 | 2012 | 9358 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 2 | 2011 | 1804 | 0.090 |
Why?
|
| Constriction, Pathologic | 3 | 2004 | 1104 | 0.090 |
Why?
|
| Phototherapy | 1 | 1993 | 368 | 0.090 |
Why?
|
| Apoptosis | 4 | 2015 | 9514 | 0.090 |
Why?
|
| Focal Infection | 1 | 1989 | 9 | 0.080 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1991 | 222 | 0.080 |
Why?
|
| Renal Insufficiency | 4 | 2012 | 811 | 0.080 |
Why?
|
| Forecasting | 2 | 2017 | 2936 | 0.080 |
Why?
|
| Surgical Wound Infection | 3 | 2001 | 1547 | 0.080 |
Why?
|
| Polyamines | 3 | 1986 | 132 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 2077 | 0.080 |
Why?
|
| Anastomosis, Surgical | 5 | 1996 | 992 | 0.080 |
Why?
|
| Incidence | 7 | 2020 | 21527 | 0.080 |
Why?
|
| Drug Substitution | 1 | 2011 | 292 | 0.080 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2010 | 131 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2012 | 20710 | 0.080 |
Why?
|
| Cell Movement | 4 | 2004 | 5204 | 0.080 |
Why?
|
| Back Pain | 1 | 2012 | 547 | 0.080 |
Why?
|
| Retreatment | 2 | 2021 | 598 | 0.080 |
Why?
|
| Analysis of Variance | 6 | 2005 | 6214 | 0.080 |
Why?
|
| Paraganglioma | 1 | 2010 | 143 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 3360 | 0.070 |
Why?
|
| Models, Animal | 3 | 2015 | 2121 | 0.070 |
Why?
|
| Risk Adjustment | 1 | 2012 | 597 | 0.070 |
Why?
|
| Cardiovascular Agents | 1 | 2014 | 849 | 0.070 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 1989 | 138 | 0.070 |
Why?
|
| Celiac Artery | 1 | 2008 | 65 | 0.070 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2018 | 1549 | 0.070 |
Why?
|
| Surgical Flaps | 1 | 1996 | 1680 | 0.070 |
Why?
|
| Device Removal | 1 | 2012 | 643 | 0.070 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 701 | 0.070 |
Why?
|
| Leukocytes | 1 | 2015 | 2034 | 0.070 |
Why?
|
| Databases, Factual | 4 | 2020 | 8065 | 0.070 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 1459 | 0.070 |
Why?
|
| Combined Modality Therapy | 3 | 2016 | 8540 | 0.070 |
Why?
|
| Culture Media, Conditioned | 2 | 1999 | 521 | 0.070 |
Why?
|
| Immunoglobulin G | 2 | 1989 | 4559 | 0.070 |
Why?
|
| Splenic Artery | 1 | 2007 | 58 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2000 | 3803 | 0.070 |
Why?
|
| Decision Support Techniques | 2 | 2013 | 2007 | 0.070 |
Why?
|
| Ornithine Decarboxylase | 1 | 1986 | 63 | 0.070 |
Why?
|
| Mesentery | 1 | 2007 | 201 | 0.070 |
Why?
|
| Intestinal Polyps | 1 | 1986 | 105 | 0.070 |
Why?
|
| Abdominal Pain | 1 | 2012 | 1069 | 0.060 |
Why?
|
| Staphylococcus epidermidis | 2 | 2001 | 121 | 0.060 |
Why?
|
| Renal Dialysis | 3 | 2012 | 1790 | 0.060 |
Why?
|
| Enoxaparin | 1 | 2008 | 391 | 0.060 |
Why?
|
| Shock, Cardiogenic | 1 | 1991 | 709 | 0.060 |
Why?
|
| Groin | 1 | 2005 | 106 | 0.060 |
Why?
|
| Lung | 2 | 2015 | 10068 | 0.060 |
Why?
|
| Electroencephalography | 4 | 2017 | 6282 | 0.060 |
Why?
|
| Phenanthrenes | 1 | 2005 | 65 | 0.060 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2005 | 51 | 0.060 |
Why?
|
| Length of Stay | 5 | 2023 | 6491 | 0.060 |
Why?
|
| Pseudomonas Infections | 1 | 1989 | 622 | 0.060 |
Why?
|
| Duodenum | 1 | 2008 | 495 | 0.060 |
Why?
|
| Random Allocation | 2 | 2000 | 2394 | 0.060 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3692 | 0.060 |
Why?
|
| Constriction | 3 | 2012 | 168 | 0.060 |
Why?
|
| Prognosis | 6 | 2021 | 29959 | 0.060 |
Why?
|
| Probability | 1 | 2009 | 2476 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2921 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2846 | 0.060 |
Why?
|
| Antibodies | 1 | 2011 | 2421 | 0.050 |
Why?
|
| Durable Medical Equipment | 1 | 2003 | 23 | 0.050 |
Why?
|
| Endothelin-1 | 2 | 2015 | 297 | 0.050 |
Why?
|
| Academic Medical Centers | 2 | 2012 | 2783 | 0.050 |
Why?
|
| Photochemistry | 1 | 2003 | 239 | 0.050 |
Why?
|
| Hypertension | 1 | 2023 | 8616 | 0.050 |
Why?
|
| Critical Illness | 3 | 2011 | 2750 | 0.050 |
Why?
|
| Bacterial Infections | 1 | 1991 | 1390 | 0.050 |
Why?
|
| Aorta | 4 | 1997 | 2043 | 0.050 |
Why?
|
| Mastectomy, Radical | 1 | 2002 | 19 | 0.050 |
Why?
|
| Radionuclide Imaging | 4 | 1992 | 1986 | 0.050 |
Why?
|
| Hyperemia | 1 | 2004 | 223 | 0.050 |
Why?
|
| Running | 1 | 2007 | 488 | 0.050 |
Why?
|
| Aneurysm, Ruptured | 1 | 2008 | 455 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 1987 | 518 | 0.050 |
Why?
|
| Kidney Function Tests | 3 | 2012 | 685 | 0.050 |
Why?
|
| Photobiology | 1 | 2002 | 10 | 0.050 |
Why?
|
| Disease-Free Survival | 4 | 2016 | 6853 | 0.050 |
Why?
|
| Endoscopy | 2 | 2000 | 1854 | 0.050 |
Why?
|
| Cytokines | 2 | 2018 | 7438 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9407 | 0.050 |
Why?
|
| United States | 8 | 2016 | 72945 | 0.050 |
Why?
|
| Coronary Disease | 4 | 1996 | 5915 | 0.050 |
Why?
|
| Adult | 28 | 2021 | 223305 | 0.050 |
Why?
|
| Calcinosis | 2 | 2003 | 1480 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 694 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2001 | 6575 | 0.050 |
Why?
|
| Disability Evaluation | 2 | 2018 | 1828 | 0.050 |
Why?
|
| Pancreas | 1 | 2008 | 1698 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2020 | 2763 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2000 | 65 | 0.040 |
Why?
|
| Versicans | 1 | 2000 | 40 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2000 | 205 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 1984 | 2012 | 0.040 |
Why?
|
| Elastic Tissue | 1 | 2000 | 65 | 0.040 |
Why?
|
| beta Carotene | 3 | 1991 | 523 | 0.040 |
Why?
|
| Postoperative Period | 2 | 2004 | 1824 | 0.040 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2000 | 142 | 0.040 |
Why?
|
| Ankle Brachial Index | 2 | 2011 | 163 | 0.040 |
Why?
|
| Colonic Neoplasms | 3 | 1986 | 2535 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2000 | 283 | 0.040 |
Why?
|
| Extremities | 2 | 2004 | 869 | 0.040 |
Why?
|
| Procollagen | 1 | 2000 | 189 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 20146 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 610 | 0.040 |
Why?
|
| Fibrosis | 3 | 2007 | 2078 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 5536 | 0.040 |
Why?
|
| Pulsatile Flow | 2 | 2014 | 318 | 0.040 |
Why?
|
| Atherosclerosis | 2 | 2013 | 3421 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2012 | 3240 | 0.040 |
Why?
|
| Transplantation, Homologous | 2 | 2000 | 4860 | 0.040 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2020 | 145 | 0.040 |
Why?
|
| Microcirculation | 1 | 2004 | 1282 | 0.040 |
Why?
|
| Urinary Catheterization | 1 | 2020 | 195 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2010 | 2101 | 0.040 |
Why?
|
| Massachusetts | 2 | 2017 | 8890 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 978 | 0.040 |
Why?
|
| Blood Flow Velocity | 3 | 2014 | 1374 | 0.040 |
Why?
|
| Medicare | 2 | 2016 | 6813 | 0.040 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 2001 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2002 | 893 | 0.040 |
Why?
|
| Actuarial Analysis | 3 | 2006 | 370 | 0.040 |
Why?
|
| Antihypertensive Agents | 2 | 2023 | 2030 | 0.040 |
Why?
|
| Urodynamics | 1 | 2020 | 349 | 0.040 |
Why?
|
| Lectins | 1 | 2000 | 490 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2002 | 680 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1969 | 0.040 |
Why?
|
| Premedication | 2 | 1989 | 245 | 0.040 |
Why?
|
| Intraoperative Care | 3 | 2005 | 768 | 0.040 |
Why?
|
| Intestines | 2 | 2021 | 1904 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 1986 | 6359 | 0.040 |
Why?
|
| Acute Disease | 3 | 2021 | 7240 | 0.040 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2006 | 2028 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 3 | 2014 | 874 | 0.040 |
Why?
|
| Immunosuppressive Agents | 3 | 2015 | 4215 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 2018 | 365 | 0.040 |
Why?
|
| Endpoint Determination | 1 | 2020 | 592 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2005 | 1188 | 0.040 |
Why?
|
| Rectal Neoplasms | 1 | 1986 | 1183 | 0.040 |
Why?
|
| Hospitals, Private | 2 | 2009 | 67 | 0.040 |
Why?
|
| Growth Substances | 1 | 1999 | 759 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1999 | 616 | 0.030 |
Why?
|
| Inflammation | 4 | 2013 | 10863 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2009 | 7475 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2000 | 806 | 0.030 |
Why?
|
| Injections, Intralesional | 1 | 1998 | 280 | 0.030 |
Why?
|
| Myocardial Revascularization | 1 | 2001 | 795 | 0.030 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1996 | 48 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2000 | 592 | 0.030 |
Why?
|
| Fibrinolytic Agents | 2 | 2018 | 2078 | 0.030 |
Why?
|
| Nucleosomes | 1 | 2000 | 492 | 0.030 |
Why?
|
| Mesenteric Arteries | 2 | 2001 | 177 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 2189 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2004 | 1407 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 1892 | 0.030 |
Why?
|
| Rats, Inbred Strains | 4 | 1992 | 2078 | 0.030 |
Why?
|
| Rats, Inbred ACI | 1 | 1995 | 34 | 0.030 |
Why?
|
| Vocal Cords | 1 | 2020 | 520 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2000 | 1587 | 0.030 |
Why?
|
| Podiatry | 1 | 2016 | 28 | 0.030 |
Why?
|
| Regional Blood Flow | 2 | 2011 | 1478 | 0.030 |
Why?
|
| Hemostasis, Surgical | 2 | 1996 | 128 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2012 | 10384 | 0.030 |
Why?
|
| Duodenal Diseases | 1 | 1996 | 101 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10451 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2002 | 21162 | 0.030 |
Why?
|
| Omentum | 1 | 1996 | 168 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2015 | 511 | 0.030 |
Why?
|
| Cerebral Angiography | 2 | 2018 | 1263 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 1986 | 3041 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 1996 | 222 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2004 | 1217 | 0.030 |
Why?
|
| DNA | 4 | 2000 | 7210 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 3246 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 1995 | 310 | 0.030 |
Why?
|
| Paraplegia | 2 | 2011 | 161 | 0.030 |
Why?
|
| Diagnosis, Differential | 4 | 2010 | 12985 | 0.030 |
Why?
|
| Blood Coagulation Factors | 1 | 1996 | 371 | 0.030 |
Why?
|
| Endothelium | 1 | 1997 | 768 | 0.030 |
Why?
|
| New England | 1 | 2017 | 1058 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 1988 | 2596 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2004 | 9244 | 0.030 |
Why?
|
| Positron-Emission Tomography | 2 | 2010 | 6548 | 0.030 |
Why?
|
| Mannitol | 1 | 2014 | 176 | 0.030 |
Why?
|
| Disaccharides | 1 | 2014 | 170 | 0.030 |
Why?
|
| Sensitivity and Specificity | 4 | 2004 | 14653 | 0.030 |
Why?
|
| Organ Preservation Solutions | 1 | 2014 | 105 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 2 | 1994 | 1478 | 0.030 |
Why?
|
| Intraoperative Period | 2 | 1995 | 512 | 0.030 |
Why?
|
| Subclavian Artery | 1 | 2014 | 138 | 0.030 |
Why?
|
| Histidine | 1 | 2014 | 301 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 1995 | 1168 | 0.030 |
Why?
|
| Cohort Studies | 6 | 2009 | 41706 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1995 | 939 | 0.030 |
Why?
|
| Laser Coagulation | 1 | 1996 | 335 | 0.030 |
Why?
|
| Electrolytes | 1 | 2014 | 279 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 2015 | 726 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1994 | 2551 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 3208 | 0.030 |
Why?
|
| Chemokine CXCL2 | 1 | 2013 | 105 | 0.030 |
Why?
|
| Hemodynamics | 3 | 2016 | 4188 | 0.030 |
Why?
|
| Glutamates | 1 | 2014 | 384 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2018 | 1968 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 1999 | 1469 | 0.030 |
Why?
|
| Upper Extremity | 1 | 2018 | 684 | 0.030 |
Why?
|
| Plethysmography | 1 | 1993 | 172 | 0.030 |
Why?
|
| Actins | 1 | 2000 | 2061 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2014 | 431 | 0.030 |
Why?
|
| Life Tables | 3 | 2000 | 367 | 0.030 |
Why?
|
| Neodymium | 1 | 1992 | 20 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2001 | 1429 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1998 | 1331 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 685 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2015 | 609 | 0.030 |
Why?
|
| Yttrium | 1 | 1992 | 33 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2000 | 5022 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 1998 | 11062 | 0.020 |
Why?
|
| Prospective Studies | 10 | 2020 | 54872 | 0.020 |
Why?
|
| Half-Life | 1 | 1993 | 648 | 0.020 |
Why?
|
| Hospital Mortality | 2 | 2019 | 5344 | 0.020 |
Why?
|
| Thallium Radioisotopes | 1 | 1992 | 138 | 0.020 |
Why?
|
| Risk | 1 | 2004 | 9602 | 0.020 |
Why?
|
| Glutathione | 1 | 2014 | 589 | 0.020 |
Why?
|
| Dipyridamole | 1 | 1992 | 143 | 0.020 |
Why?
|
| Hypothermia, Induced | 1 | 1997 | 754 | 0.020 |
Why?
|
| Paraparesis | 1 | 2011 | 15 | 0.020 |
Why?
|
| Isoantibodies | 1 | 2015 | 681 | 0.020 |
Why?
|
| Venae Cavae | 1 | 1991 | 41 | 0.020 |
Why?
|
| Collagen | 1 | 1999 | 2635 | 0.020 |
Why?
|
| Neutrophils | 1 | 2004 | 3782 | 0.020 |
Why?
|
| Citrates | 1 | 1991 | 132 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2015 | 753 | 0.020 |
Why?
|
| Polyethylene Terephthalates | 1 | 1991 | 112 | 0.020 |
Why?
|
| Citric Acid | 1 | 1991 | 124 | 0.020 |
Why?
|
| Bioprosthesis | 1 | 1995 | 593 | 0.020 |
Why?
|
| Spectrophotometry | 2 | 1988 | 291 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2004 | 4047 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2006 | 4306 | 0.020 |
Why?
|
| Wound Healing | 2 | 2000 | 2800 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2014 | 793 | 0.020 |
Why?
|
| Medical Records | 1 | 2016 | 1408 | 0.020 |
Why?
|
| DNA Damage | 1 | 2000 | 2469 | 0.020 |
Why?
|
| Ligation | 2 | 2007 | 446 | 0.020 |
Why?
|
| Heart Diseases | 2 | 2018 | 2817 | 0.020 |
Why?
|
| Rabbits | 3 | 1993 | 4752 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 2 | 1985 | 5444 | 0.020 |
Why?
|
| Collateral Circulation | 1 | 2011 | 289 | 0.020 |
Why?
|
| Endoscopes | 1 | 1990 | 169 | 0.020 |
Why?
|
| Hypolipidemic Agents | 1 | 2014 | 609 | 0.020 |
Why?
|
| Ornithine | 2 | 1986 | 79 | 0.020 |
Why?
|
| Comorbidity | 2 | 2014 | 10580 | 0.020 |
Why?
|
| Splanchnic Circulation | 1 | 2009 | 122 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 10101 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1997 | 1811 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2013 | 3511 | 0.020 |
Why?
|
| Young Adult | 2 | 2012 | 59939 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2002 | 8045 | 0.020 |
Why?
|
| Motor Activity | 1 | 2018 | 2711 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 1989 | 570 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2013 | 1156 | 0.020 |
Why?
|
| Equipment Design | 2 | 1996 | 3488 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 1992 | 642 | 0.020 |
Why?
|
| Hemoglobin A | 1 | 1988 | 84 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2023 | 3850 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2018 | 2978 | 0.020 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2008 | 36 | 0.020 |
Why?
|
| Evoked Potentials, Motor | 1 | 2011 | 463 | 0.020 |
Why?
|
| Atherectomy | 1 | 2007 | 41 | 0.020 |
Why?
|
| Arteriovenous Fistula | 1 | 1991 | 320 | 0.020 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 1988 | 68 | 0.020 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 1990 | 291 | 0.020 |
Why?
|
| Abdomen, Acute | 1 | 2008 | 122 | 0.020 |
Why?
|
| Dogs | 1 | 1992 | 3834 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2017 | 5990 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2002 | 3683 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 1989 | 958 | 0.020 |
Why?
|
| Spermidine | 1 | 1986 | 63 | 0.020 |
Why?
|
| Tissue and Organ Procurement | 1 | 2015 | 987 | 0.020 |
Why?
|
| Spermine | 1 | 1986 | 70 | 0.020 |
Why?
|
| Safety | 1 | 1991 | 1157 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2018 | 2809 | 0.020 |
Why?
|
| Vanadium | 1 | 1986 | 54 | 0.020 |
Why?
|
| Ticlopidine | 1 | 2011 | 729 | 0.020 |
Why?
|
| Thymidine | 1 | 1986 | 297 | 0.020 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 1985 | 40 | 0.020 |
Why?
|
| Disease Progression | 2 | 2014 | 13642 | 0.020 |
Why?
|
| Shock, Hemorrhagic | 1 | 2008 | 224 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1993 | 2629 | 0.020 |
Why?
|
| Mitochondria | 1 | 1999 | 3678 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2011 | 775 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 2005 | 1767 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10619 | 0.020 |
Why?
|
| Tibial Arteries | 1 | 2005 | 60 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3621 | 0.020 |
Why?
|
| Administration, Oral | 2 | 1991 | 4019 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 1672 | 0.020 |
Why?
|
| Tomography, Spiral Computed | 1 | 2007 | 273 | 0.020 |
Why?
|
| Shock | 1 | 2008 | 316 | 0.020 |
Why?
|
| Warfarin | 1 | 1994 | 1493 | 0.020 |
Why?
|
| Ulcer | 1 | 2006 | 203 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 1998 | 2513 | 0.020 |
Why?
|
| Aphasia | 1 | 1987 | 193 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2000 | 12795 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 1984 | 5860 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2004 | 36570 | 0.010 |
Why?
|
| Cheek | 1 | 1984 | 66 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1984 | 256 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1996 | 3464 | 0.010 |
Why?
|
| Aneurysm, False | 1 | 2006 | 264 | 0.010 |
Why?
|
| Regeneration | 1 | 2013 | 1520 | 0.010 |
Why?
|
| Shear Strength | 1 | 2004 | 160 | 0.010 |
Why?
|
| Postoperative Care | 2 | 2005 | 1480 | 0.010 |
Why?
|
| Ileum | 1 | 1986 | 558 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2016 | 3957 | 0.010 |
Why?
|
| Hospitals, Veterans | 1 | 2006 | 395 | 0.010 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1985 | 215 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2005 | 420 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 8928 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1996 | 2505 | 0.010 |
Why?
|
| Body Temperature | 2 | 1997 | 780 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2008 | 1838 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2013 | 3226 | 0.010 |
Why?
|
| Oxygen | 1 | 2014 | 4252 | 0.010 |
Why?
|
| Regression Analysis | 4 | 1995 | 6329 | 0.010 |
Why?
|
| Aspirin | 1 | 2014 | 3134 | 0.010 |
Why?
|
| Anesthesia, Conduction | 1 | 2006 | 264 | 0.010 |
Why?
|
| Methods | 2 | 1995 | 1065 | 0.010 |
Why?
|
| Colon | 2 | 1991 | 1797 | 0.010 |
Why?
|
| Myocardium | 1 | 2015 | 4765 | 0.010 |
Why?
|
| Bile Duct Neoplasms | 1 | 1988 | 614 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2000 | 11924 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 22351 | 0.010 |
Why?
|
| Creatinine | 2 | 1999 | 1917 | 0.010 |
Why?
|
| Linear Models | 1 | 1992 | 5873 | 0.010 |
Why?
|
| Finite Element Analysis | 1 | 2004 | 441 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 1697 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2009 | 2425 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 3934 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 5888 | 0.010 |
Why?
|
| Cricetinae | 1 | 1984 | 2416 | 0.010 |
Why?
|
| Telemedicine | 1 | 1998 | 3111 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 15652 | 0.010 |
Why?
|
| Buttocks | 1 | 2000 | 111 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 2727 | 0.010 |
Why?
|
| Mice | 5 | 2013 | 81898 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 11514 | 0.010 |
Why?
|
| Pressure Ulcer | 1 | 2000 | 158 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1991 | 10745 | 0.010 |
Why?
|
| Morbidity | 1 | 2004 | 1754 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14473 | 0.010 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 1997 | 38 | 0.010 |
Why?
|
| Sepsis | 1 | 2011 | 2604 | 0.010 |
Why?
|
| Alcoholism | 1 | 2008 | 1980 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5753 | 0.010 |
Why?
|
| Erectile Dysfunction | 1 | 2000 | 437 | 0.010 |
Why?
|
| Carbohydrate Epimerases | 1 | 1975 | 46 | 0.010 |
Why?
|
| Triose-Phosphate Isomerase | 1 | 1975 | 45 | 0.010 |
Why?
|
| Eflornithine | 2 | 1986 | 31 | 0.010 |
Why?
|
| Thermometers | 1 | 1996 | 42 | 0.010 |
Why?
|
| Epidural Space | 1 | 1997 | 123 | 0.010 |
Why?
|
| Electronics, Medical | 1 | 1996 | 70 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 1622 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2002 | 2659 | 0.010 |
Why?
|
| Microcomputers | 1 | 1996 | 139 | 0.010 |
Why?
|
| Fibrinolysis | 1 | 1996 | 331 | 0.010 |
Why?
|
| Pulse | 1 | 1995 | 217 | 0.010 |
Why?
|
| Photography | 1 | 1998 | 536 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1996 | 820 | 0.010 |
Why?
|
| Compliance | 1 | 1994 | 100 | 0.010 |
Why?
|
| Infrared Rays | 1 | 1996 | 246 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 2144 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 1997 | 540 | 0.010 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1995 | 331 | 0.010 |
Why?
|
| Pedigree | 2 | 1993 | 4539 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 1995 | 464 | 0.010 |
Why?
|
| Pressure | 1 | 1996 | 1172 | 0.010 |
Why?
|
| Elasticity | 1 | 1994 | 654 | 0.010 |
Why?
|
| Feedback | 1 | 1996 | 797 | 0.010 |
Why?
|
| Reference Values | 2 | 1990 | 4914 | 0.010 |
Why?
|
| Macrophages | 1 | 2006 | 5784 | 0.010 |
Why?
|
| Tensile Strength | 1 | 1992 | 332 | 0.010 |
Why?
|
| Contrast Media | 2 | 1995 | 5329 | 0.010 |
Why?
|
| Anisotropy | 1 | 1994 | 1286 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 1998 | 1129 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2004 | 6258 | 0.010 |
Why?
|
| Sutures | 1 | 1992 | 283 | 0.010 |
Why?
|
| Gadolinium | 1 | 1995 | 964 | 0.010 |
Why?
|
| Retroperitoneal Space | 1 | 1990 | 175 | 0.010 |
Why?
|
| Temperature | 1 | 1996 | 2231 | 0.000 |
Why?
|
| Peritoneum | 1 | 1990 | 227 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1986 | 11657 | 0.000 |
Why?
|
| Absorption | 1 | 1988 | 242 | 0.000 |
Why?
|
| Blood Pressure | 1 | 2004 | 8533 | 0.000 |
Why?
|
| Cystic Duct | 1 | 1988 | 18 | 0.000 |
Why?
|
| Hepatic Duct, Common | 1 | 1988 | 48 | 0.000 |
Why?
|
| Rest | 1 | 1993 | 940 | 0.000 |
Why?
|
| Kidney Neoplasms | 1 | 1985 | 4282 | 0.000 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 1988 | 121 | 0.000 |
Why?
|
| Critical Care | 1 | 2000 | 2714 | 0.000 |
Why?
|
| Sheep | 1 | 1990 | 1448 | 0.000 |
Why?
|
| Feasibility Studies | 1 | 1998 | 5306 | 0.000 |
Why?
|
| 1,2-Dimethylhydrazine | 1 | 1986 | 8 | 0.000 |
Why?
|
| Dimethylhydrazines | 1 | 1986 | 12 | 0.000 |
Why?
|
| Respiration Disorders | 1 | 1990 | 364 | 0.000 |
Why?
|
| Cocarcinogenesis | 1 | 1986 | 49 | 0.000 |
Why?
|
| RNA | 2 | 1986 | 2715 | 0.000 |
Why?
|
| Pain | 1 | 2000 | 5098 | 0.000 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1988 | 520 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1994 | 2253 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1988 | 1529 | 0.000 |
Why?
|
| Exercise Test | 1 | 1992 | 2188 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1994 | 1931 | 0.000 |
Why?
|
| Colonoscopy | 1 | 1991 | 1409 | 0.000 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1985 | 496 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1985 | 13644 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1986 | 1419 | 0.000 |
Why?
|
| Adaptation, Physiological | 1 | 1986 | 1312 | 0.000 |
Why?
|
| Emergencies | 1 | 1985 | 1223 | 0.000 |
Why?
|
| Smoking | 1 | 1994 | 9077 | 0.000 |
Why?
|
| Hydroxymercuribenzoates | 1 | 1975 | 4 | 0.000 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 1975 | 22 | 0.000 |
Why?
|
| Aging | 1 | 1994 | 8728 | 0.000 |
Why?
|
| Body Weight | 1 | 1986 | 4626 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1975 | 2478 | 0.000 |
Why?
|
| Muscles | 1 | 1975 | 1576 | 0.000 |
Why?
|
| Kinetics | 1 | 1975 | 6288 | 0.000 |
Why?
|
| Binding Sites | 1 | 1975 | 6013 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1975 | 2678 | 0.000 |
Why?
|
| Protein Binding | 1 | 1975 | 9326 | 0.000 |
Why?
|
| Adolescent | 1 | 1988 | 88902 | 0.000 |
Why?
|